Machine perfusion or cold storage in organ transplantation: indication, mechanisms, and future perspectives

Transpl Int. 2010 Jun;23(6):561-70. doi: 10.1111/j.1432-2277.2009.01047.x. Epub 2010 Jan 13.

Abstract

Most organs are currently preserved by cold storage (CS) prior to transplantation. However, as more so called marginal donor organs are utilized, machine perfusion has regained clinical interest. Recent studies have demonstrated advantages of pulsatile perfusion over CS preservation for kidney transplantation. However, it remains unclear whether there is a significant benefit of one preservation method over the other in general, or, whether the utilization of particular preservation approaches needs to be linked to organ characteristics. Proposed protective mechanisms of pulsatile perfusion remain largely obscure. It can be speculated that pulsatile perfusion may not only provide nutrition and facilitate the elimination of toxins but also trigger protective mechanisms leading to the amelioration of innate immune responses. Those aspects may be of particular relevance when utilizing grafts with suboptimal quality which may have an increased vulnerability to ischemia/reperfusion injury and compromised repair mechanisms. This review aims to enunciate the principles of organ perfusion and preservation as they relate to indication, aspects of organ protection and to highlight future developments.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cold Temperature
  • Cryopreservation / methods*
  • Glucose
  • Humans
  • Mannitol
  • Organ Preservation / methods*
  • Organ Preservation / trends
  • Organ Preservation Solutions
  • Perfusion / methods*
  • Potassium Chloride
  • Procaine
  • Pulsatile Flow*

Substances

  • Bretschneider cardioplegic solution
  • Organ Preservation Solutions
  • Mannitol
  • Procaine
  • Potassium Chloride
  • Glucose